Mahkam Zanganeh - 29 Apr 2025 Form 4 Insider Report for Summit Therapeutics Inc. (SMMT)

Role
Co-Chief Executive Officer, Director, 10%+ Owner
Signature
/s/ Mahkam Zanganeh
Issuer symbol
SMMT
Transactions as of
29 Apr 2025
Net transactions value
$0
Form type
4
Filing time
01 May 2025, 18:03:44 UTC
Previous filing
09 Apr 2025
Next filing
02 Jun 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SMMT Stock Option (right to buy) Award +1,040,000 1,040,000 29 Apr 2025 Common Stock 1,040,000 $1.06 Direct F1, F2
transaction SMMT Stock Option (right to buy) Award +400,000 400,000 29 Apr 2025 Common Stock 400,000 $1.29 Direct F1, F2
transaction SMMT Stock Option (right to buy) Award +9,590,558 9,590,558 29 Apr 2025 Common Stock 9,590,558 $1.68 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Effective April 29, 2025, these stock options were amended from performance-based stock options to time-based stock options. The shares underlying the option vest as follows: (i) 50% of such shares vested as of April 29, 2025, and (ii) the remaining 50% of such shares vest in three equal annual installments, with the first such installment occurring on October 13, 2025.
F2 Not applicable.